This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castillo, A. R.
Right arrow Articles by Ottemann, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castillo, A. R.
Right arrow Articles by Ottemann, K. M.

 Previous Article  |  Next Article 

Infection and Immunity, December 2008, p. 5632-5644, Vol. 76, No. 12
0019-9567/08/$08.00+0     doi:10.1128/IAI.00627-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Recombination-Based In Vivo Expression Technology Identifies Helicobacter pylori Genes Important for Host Colonization{triangledown} ,{dagger}

Andrea R. Castillo,* Andrew J. Woodruff, Lynn E. Connolly,{ddagger} William E. Sause, and Karen M. Ottemann*

Department of Environmental Toxicology, University of California, Santa Cruz, 1156 High St., Santa Cruz, California 95064

Received 21 May 2008/ Returned for modification 23 June 2008/ Accepted 28 August 2008


arrow
ABSTRACT
 
Here we undertook to identify colonization and gastric disease-promoting factors of the human gastric pathogen Helicobacter pylori as genes that were induced in response to the stomach environment. Using recombination-based in vivo expression technology (RIVET), we identified six promoters induced in the host compared to laboratory conditions. Three of these promoters, designated Pivi10, Pivi66, and Pivi77, regulate genes that H. pylori may use to interact with other microbes or the host. Pivi10 likely regulates the mobA, mobB, and mobD genes, which have potential roles in horizontal gene transfer through plasmid mobilization. Pivi66 occurs in the cytotoxin-associated gene pathogenicity island, a genomic region known to be associated with more severe disease outcomes, and likely regulates cagZ, virB11, and virD4. Pivi77 likely regulates HP0289, an uncharacterized paralogue of the vacA cytotoxin gene. We assessed the roles of a subset of these genes in colonization by creating deletion mutants and analyzing them in single-strain and coinfection experiments. We found that a mobABD mutant was defective for murine host colonization and that a cagZ mutant outcompeted the wild-type strain in a coinfection analysis. Our work supports the conclusion that RIVET is a valuable tool for identifying H. pylori factors with roles in host colonization.


arrow
INTRODUCTION
 
Helicobacter pylori is a gram-negative bacterium that colonizes the stomachs of 50% of the world's population (66). About 10% of H. pylori infections result in severe gastritis, gastric ulcers, gastric cancer, and mucosa-associated lymphoid tissue lymphoma (67, 86). Variability in the genetics of both the infecting H. pylori strains and the infected hosts likely contributes to the wide range of disease outcomes (8). The goals of this work were to identify additional H. pylori virulence factors that contribute to host colonization and/or to disease development and to characterize their roles in virulence.

Several virulence factors that aid H. pylori in colonization of the host and contribute to disease development have been identified by a variety of methods. One of these factors is the urease enzyme that H. pylori needs to survive in the low-pH gastric lumen as it makes its way to the gastric mucosa, which has a more neutral pH (58). The urease enzyme buffers the bacterium by converting host-produced urea into NH3 and CO2. H. pylori also requires several motility and chemotaxis genes for colonization, presumably so that it can locate and move to its preferred site of infection and remain there (27, 28, 31, 64). Autotransporters, including the VacA protein, contribute to host colonization in several ways, possibly by damaging epithelial cells and by interfering with antigen presentation (25, 57, 68, 71, 83). Other putative autotransporters encoded by babA and sabA help H. pylori adhere to the gastric epithelium, likely preventing bacterial shedding with epithelial cell turnover and mucus flow (40, 54). Although not required for host colonization, the H. pylori virulence factor NapA (neutrophil activating protein A) contributes to disease development, as it promotes inflammation by attracting neutrophils and monocytes to the site of infection and also stimulates the release of reactive oxygen species from leukocytes (75). Another protein found to contribute to inflammation is OipA (outer inflammatory protein A) (91). Finally, a quite well-known H. pylori virulence factor is the cytotoxin-associated gene (CAG) pathogenicity island and the effector CagA. The type IV secretion apparatus encoded by CAG pathogenicity island genes promotes inflammation and injection of the effectors CagA and peptidoglycan into the host epithelial cell and provokes cell dysfunction that can lead to cell transformation (35, 60, 88).

Recently, several semiglobal screens have been used to identify additional H. pylori genes that are required for host colonization and/or contribute to gastric disease. Two studies used in vivo screens with libraries of transposon-mutagenized H. pylori strains to identify genes required for H. pylori host colonization (6, 41). In both of these cases, the H. pylori strains used to infect the host were compared with strains recovered from the stomach to find genes required for viability in the host (6, 41). These studies identified some genes that the strains had in common and some unique genes. Two other studies focused on H. pylori genes induced in response to the host. Two of the known H. pylori virulence factors, UreA and NapA, were induced during infection of the host (9), supporting the conclusion that this strategy is a good strategy for identifying other virulence factors. One study used selective capture of transcribed sequence analysis to isolate H. pylori transcripts that were induced in human biopsies and experimentally infected gerbils and compared their expression under these conditions with the expression in culture (34). A second study used microarrays to compare H. pylori in vivo gene expression to expression under in vitro culture conditions (78). Although these analyses identified genes induced during host infection, each of them had its limitations. For example, the transposon mutagenesis screens did not analyze essential genes, and the transcript induction screens identified only genes that were induced at the time of RNA isolation. Thus, our goal was to identify new H. pylori virulence factors that may have been missed by these analyses.

Here we describe the use of recombination-based in vivo expression technology (RIVET) to identify H. pylori promoters induced in response to the murine host. RIVET is a variant of the original in vivo expression technology (53) in which a promoter transcriptional event is captured permanently as a conversion of the infecting strain from antibiotic resistant to antibiotic sensitive (Fig. 1) (17). The RIVET approach has been used with Vibrio cholerae, Lactobacillus plantarum, Staphylococcus aureus, Mycobacterium tuberculosis, and Bordetella pertussis (14, 18, 51, 76, 87). Here we describe how we modified the RIVET system for use with H. pylori. Using the RIVET system, we screened a ~3,000-member library of potential H. pylori promoters in mice and found that 6 of them were reliably host induced. The genes regulated by these promoters include three genes with potential roles in H. pylori secretion systems; these genes encode Mob-like proteins potentially required for bacterial conjugation, the CagZ protein present in the CAG pathogenicity island, and the VacA paralogue encoded by HP0289. To determine whether these gene products affected animal colonization, we constructed and analyzed mobABD and cagZ gene deletion mutants. We found that the H. pylori {Delta}mobABD mutant was defective for host colonization, while the {Delta}cagZ mutant actually outcompeted the wild-type parent strain in competition coinfection analyses. Our work supports the conclusion that the RIVET system is a valuable tool for identifying H. pylori genes important for host colonization.


Figure 1
View larger version (9K):
[in this window]
[in a new window]

  		FIG. 1. RIVET for use with H. pylori. (A) An H. pylori RIVET strain contains two RIVET components located in the chromosome, a promoterless tnpR gene that encodes the site-specific recombinase integrated at the H. pylori rdxA locus (diagram 1) and a cassette in which the aphA3 gene (also designated Km) that confers Kmr is cloned between res1 sequences (res1-Km-res1) integrated at the HP0294-HP0295 intergenic locus (diagram 2). In the absence of an upstream promoter, tnpR is not expressed and the H. pylori strain remains Kmr. (B) In the presence of an upstream promoter (P), tnpR is expressed (diagram 1), and the TnpR recombinase binds the res1 sequences to catalyze removal of the Km gene cloned between these sequences (diagram 2), converting the H. pylori strain to Kms (diagram 3).


arrow
MATERIALS AND METHODS
 
Bacterial strains, growth conditions, and antibiotics. H. pylori strain mG27 is a mouse-adapted descendant of clinical isolate G27 (19, 23). mG27 was generated by serially passaging the G27 H. pylori strain in mice (19). All H. pylori strains were cultured on Columbia horse blood agar (CHBA) or in brucella broth supplemented with 10% fetal bovine serum (BB10) and were grown at 37°C under microaerobic conditions with a gas mixture containing 5 to 10% O2, 10% CO2, and 80 to 85% N2. Antibiotics selective for H. pylori were added at a concentration of either 13 µg/ml (for chloramphenicol [Cm]) or 15 µg/ml (for kanamycin [Km]). Escherichia coli was cultured on Luria-Bertani (LB) agar plates or in liquid media containing ampicillin (Amp) at a final concentration of 100 µg/ml. E. coli strains were stored at –80°C in 25 to 40% glycerol. H. pylori strains were stored at –80°C in brain heart infusion media supplemented with 10% fetal bovine serum, 1% (wt/vol) β-cyclodextrin, 25% glycerol, and 5% dimethyl sulfoxide.

Plasmid construction. (i) pcat-T-tnpR. To identify promoters that are induced during infection of animals, we created plasmid pcat-T-tnpR, which has a promoterless tnpR gene that recombines in the H. pylori chromosome (Fig. 2A). This plasmid contains the Campylobacter coli gene for Cm resistance (Cmr) (cat), a strong E. coli transcriptional terminator (rrnBT1T2) (62), and a promoterless tnpR gene, all of which are flanked by sequences of the H. pylori rdxA gene. cat is transcribed from its own promoter, and the strong E. coli terminator rrnBT1T2, prevents read-through transcription into tnpR (19). The pcat-T-tnpR plasmid directs recombination into the middle of the rdxA locus on the H. pylori chromosome (80). rdxA was used because loss of this gene does not alter in vitro growth rates or the ability to infect mice (84). Upstream of the tnpR gene there is a unique BglII site into which the H. pylori genomic library was cloned.


Figure 2
View larger version (18K):
[in this window]
[in a new window]

  		FIG. 2. Construction and screening of the pcat-T-lib-tnpR and H. pylori RIVET libraries. (A) The H. pylori RIVET library in E. coli (pcat-T-lib-tnpR) was generated by cloning Sau3A-digested H. pylori genomic DNA into the BglII site upstream of tnpR in plasmid pcat-T-tnpR. Approximately 12,000 independent clones were propagated in E. coli, and the average insert size was 1.0 kb. (B) The H. pylori RIVET library (pcat-T-lib-tnpR) was integrated into the H. pylori rdxA chromosomal locus of H. pylori strain ACHP17, which contained the res1-Km-res1 cassette at an unlinked chromosomal locus. RIVET library transformants were selected on Cm-containing media. (C) In vitro expression clones were removed from the H. pylori RIVET library as transformants that converted to Kms in the lab. A total of 3,340 Cmr Kmr transformants were in our H. pylori RIVET library. (D) Fifty independent H. pylori RIVET library clones were simultaneously screened in each of two mice for in vivo induction (conversion to Kms). After 2-weeks of infection, mouse stomachs were harvested and plated on CHBA containing Cm to isolate H. pylori. The plates containing CHBA supplemented with Cm were then replica plated on CHBA containing Km (Km+ media) to identify in vivo-induced Kms clones.

(ii) pAW2rkr2. The res1-Km-res1 cassette was generated by cloning the C. coli aphA3 gene that confers Kmr (designated Km) between two res1 sequences from plasmid pSL134 (82). The res1-Km-res1 cassette was subsequently cloned into the HindIII site of pMW2 (19) in the cloned intergenic region between the convergently expressed H. pylori genes HP0294 and HP0295. The resulting plasmid was designated pAW2rkr2 (19). Plasmid pAW2rkr2 targets res1-Km-res1 to the HP0294-HP0295 intergenic locus. Strain mG27 bearing this construct was designated ACHP17 (Table 1). Studies of H. pylori strains mG27 and SS1 containing this insertion indicated that the modification had no deleterious effects on either growth or mouse colonization (data not shown).


View this table:
[in this window]
[in a new window]

  		TABLE 1. Strains and plasmids used in this study

Generating a library of potential promoters, pcat-T-lib-tnpR. We generated a library of potential promoters by ligating partially Sau3A-digested genomic DNA isolated from H. pylori strain mG27 into the BglII site of the pcat-T-tnpR vector (Fig. 2A). We selected Sau3A-digested DNA fragments ranging from 1 to 4 kb long for the library by agarose gel purification. The ligated plasmids were electroporated into E. coli DH10B and plated onto LB medium containing Amp. Approximately 12,000 individual Ampr colonies were pooled and grown in LB broth containing Amp, and DNA was isolated using a midiprep kit (Qiagen) to generate pcat-T-lib-tnpR.

Generating the H. pylori RIVET library. To create the H. pylori RIVET library, pcat-T-lib-tnpR was used to transform H. pylori strain ACHP17 (mG27 HP0294/HP0295::res1-Km-res1) (Table 1) to Cmr (Fig. 2B). To minimize the number of in vitro-expressed promoter-containing clones in our H. pylori RIVET library, we passaged Cmr transformants on CHBA containing Cm twice before selecting for Kmr. This step allowed in vitro-expressed clones to transcribe tnpR, resolve res1-Km-res1, and convert to Kms (Fig. 2C). Clones that did not express tnpR in the lab remained Kmr and were used to generate frozen stocks for our H. pylori RIVET library. Independent library clones were pooled to obtain batches containing 10 clones and stored at –80°C. The H. pylori RIVET library consisted of ~3,000 clones.

Analysis of pcat-T-lib-tnpR and the H. pylori RIVET library. Both pcat-T-lib-tnpR and the H. pylori RIVET library were analyzed to determine the diversity and the level of H. pylori genome coverage. We analyzed 30 clones obtained from the pcat-T-lib-tnpR library and 30 clones from the H. pylori RIVET library by isolating plasmid DNA and genomic DNA, respectively. The cloned H. pylori DNA was amplified from the templates by PCR using oligonucleotide rrnB1 or catseqst and oligonucleotide tnpRbk75 (Table 2). The presence and approximate sizes of the cloned H. pylori DNA fragments were determined by agarose gel electrophoresis. Cloned fragments that were similar sizes were sequenced to determine their uniqueness (Berkeley DNA Sequencing Facility, Berkeley CA). The levels of H. pylori genome coverage for the pcat-T-lib-tnpR and H. pylori RIVET libraries were determined using the following formula: N = ln (1 – P)/ln(1 – I/G), where P is the probability of obtaining all clones (we used 99%), I is the insert size (we used the calculated average insert sizes, 1.0 kb for the pcat-T-lib-tnpR library and 0.65 kb for the H. pylori RIVET library), and G is the genome size (1.8 x 103 kb) (2a). Based on our calculations, the pcat-T-lib-tnpR library covered the H. pylori genome ~4.7 times and the H. pylori RIVET library covered 84% of the H. pylori genome.


View this table:
[in this window]
[in a new window]

  		TABLE 2. Oligonucleotides used in this study

Screening the H. pylori RIVET library for in vivo-induced promoters. All animal protocols were approved by the Institutional Animal Use and Care Committee. Fifty H. pylori RIVET strains were screened simultaneously for promoter induction in each of two FVB/N mice (Charles River) (Fig. 2D). Five groups of 10 H. pylori RIVET strains were grown on CHBA containing Km to maintain Kmr. Immediately prior to infection of mice, the 50 strains were resuspended in BB10. The bacterial concentration was determined by determining the optical density at 600 nm (OD600), and the culture volume was adjusted with BB10 to obtain a bacterial concentration of ~5 x 107 cells/ml. Approximately 1 ml of the RIVET strain mixture was used to infect each of two FVB/N mice that were 4 to 6 weeks old by oral gavage by using a 20-gauge, 38-mm-long needle (Popper). Infections were allowed to persist for 2 weeks, after which we harvested and processed the mouse stomachs as described by Ottemann and Lowenthal (64). In brief, the stomachs were homogenized in 500 µl BB10 using a sterile pestle, and dilutions were plated on CHBA plates. The plates were incubated for 4 days at 37°C under microaerobic conditions. H. pylori colonies from these plates were then replica plated on both plates containing CHBA and plates containing CHBA supplemented with Km to identify Kms H. pylori RIVET strains that induced expression of tnpR in vivo. Kms RIVET strains were isolated from the corresponding CHBA plates for further analysis (Fig. 2D). These strains were designated using ivi (for in vivo-induced RIVET strain) plus a number (e.g., ivi2), and the H. pylori DNA cloned upstream of tnpR in these strains were designated using Pivi (for in vivo-induced promoter) plus a number (e.g., Pivi2).

Identifying in vivo-induced promoters. To obtain the sequence representing each Pivi clone, we isolated genomic DNA from the Kms H. pylori RIVET strains isolated from mice by using a Wizard genomic DNA purification kit (Promega). We then amplified the cloned Pivi region using oligonucleotides that annealed to the cat gene upstream of the cloned region (oligonucleotide catseqst) and the tnpR gene downstream of the cloned region (oligonucleotide tnpRbk75) (Table 2) by PCR. The sizes of the cloned fragments were estimated by agarose gel electrophoresis and were determined exactly by sequencing. The Pivi clones were sequenced using the catseqst and tnpRbk75 oligonucleotides (University of California Berkeley DNA sequencing facility). The genomic and endogenous plasmid locations of the Pivi clones were determined by comparing the sequences of the clones to the unpublished sequence of the H. pylori G27 strain genome (see Table S1 in the supplemental material). An operon analysis was done using the website http://www.microbesonline.org/.

Reconstruction of in vivo-induced strains. Since the H. pylori RIVET strains that were induced in the host removed the res1-Km-res1 cassette (and were therefore Kms), we reintroduced the res1-Km-res1 cassette into the original locus of each of these strains before we performed our secondary analysis. One Kms mouse output strain for each of the 13 unique Kms ivi strains was naturally transformed with pAW2rkr2. Transformants were selected based on Kmr, and proper integration was verified by PCR using oligonucleotides that flanked the site of integration, oligonucleotides HP0294end and HP0295end (Table 2).

Testing promoter induction in vitro and in vivo. Each of the 13 reconstructed ivi strains (strains whose designations end with R in Table 1) was analyzed to determine promoter induction conferred by the Pivi clones in the lab and in FVB/N mice. The reconstructed ivi strains were grown on CHBA containing Km prior to these analyses to maintain Kmr. In vitro promoter induction was carried out by passaging each reconstructed ivi strain on CHBA without Km for 2 weeks (five passages on fresh CHBA). Cells of the H. pylori reconstructed ivi strains were then resuspended in BB10 and plated on CHBA to obtain single colonies (~200 colonies/plate). After the plates were incubated for 4 days at 37°C under microaerobic conditions, the H. pylori colonies were replica plated on both plates containing CHBA and plates containing CHBA supplemented with Km. The level of promoter induction (expressed as a percentage) was calculated by dividing the number of Kms colonies by the total number of colonies and multiplying the result by 100. To determine the in vivo induction conferred by the Pivi regions, each reconstructed ivi strain was used independently to infect a group of FVB/N mice. After 2 weeks of infection, the mouse stomachs were harvested and plated on CHBA to isolate H. pylori. The plates were incubated for 4 days at 37°C under microaerobic conditions, and then colonies were replica plated on both plates containing CHBA and plates containing CHBA supplemented with Km to determine the number of H. pylori cells that had converted to Kms while the strains were in mice. The level of promoter induction in vivo (expressed as a percentage) was calculated by dividing the number of Kms colonies by the total number of colonies analyzed and multiplying the result by 100. The statistical significance of differences between promoter induction in vivo and promoter induction in vitro was calculated using the two-tailed Student t test.

Construction of H. pylori gene deletion mutants. We generated deletions of genes regulated by our in vivo-induced promoters by replacing a gene of interest with a nonpolar allele of the C. coli cat gene (84) that confers Cmr. Each gene replacement cassette was generated using a PCR sewing strategy (22). In brief, chromosomal regions upstream and downstream of the gene of interest were amplified using in each case (i) one oligonucleotide that annealed to the chromosome and (ii) another oligonucleotide that annealed to the chromosome and either the start or end of the cat gene. A third PCR product representing the nonpolar cat allele was generated using oligonucleotides catR2 and catF (Table 2). The PCR products representing the upstream chromosomal region, the downstream chromosomal region, and the cat gene were generated independently, purified using an agarose gel (GFX PCR DNA and gel band purification kit; GE Healthcare), and then combined. The mixture of PCR products was used as a template with the oligonucleotides that annealed to the far upstream and downstream PCR product regions. The large PCR products generated in these reactions (upstream region-cat-downstream region) were purified using an agarose gel and used to naturally transform H. pylori strains SS1 (47) and mG27 (19) to Cmr as previously described (72). All mutant strains were found to be wild type for motility by microscopic inspection and to be wild type for urease activity using a pH indicator buffer (Difco urea broth; Difco) (data not shown).

Mouse colonization analyses. H. pylori strains used for colonization analyses were passaged minimally in the lab on CHBA (two or three times) and then removed either from CHBA after growth for ~18 h or from a BB10 culture grown for ~18 h. H. pylori strains grown on CHBA were transferred to BB10 prior to infection and analyzed to determine motility and the bacterial cell concentration (OD600). H. pylori strains grown in BB10 were analyzed directly to determine motility and the bacterial cell concentration (OD600). Approximately 1 ml of an H. pylori culture containing 5 x 107 to 5 x 108 CFU/ml was used to inoculate mice by oral gavage. For single-infection studies, either a mutant H. pylori strain or the appropriate wild-type control strain was used to infect mice. For the coinfection analysis, the mutant and wild-type strains were grown separately and analyzed to determine their motilities and bacterial cell concentrations (OD600) before the cultures were mixed and used for coinfection. The bacterial cell concentrations were used to generate a mixed culture containing approximately equal numbers of cells of the mutant and wild-type strains. The actual bacterial cell concentration was determined more accurately by culture dilution and plating. Infections were allowed to persist for 2 weeks, after which the mouse stomachs were isolated and plated on CHBA as described above. The stomachs of mice infected with the mutant strains were plated on CHBA containing Cm, and the stomachs of mice infected with the wild-type strain were plated on CHBA. The stomachs of mice coinfected with both the mutant and the wild-type strain were plated on both CHBA containing Cm and CHBA. The competitive index was calculated as follows: (CFU/g for the mutant strain output/CFU/g for the wild-type strain output)/(CFU/g for the mutant strain input/CFU/g for the wild-type strain input).


arrow
RESULTS
 
We adapted the RIVET system used with great success by Camilli and Mekalanos (18) for use with H. pylori and used it to identify promoters induced in response to murine stomachs. Adapting V. cholerae RIVET for use with H. pylori required (i) creation of an H. pylori antibiotic resistance reporter for tnpR recombinase expression flanked by res1 sites (we used Kmr [res1-Km-res1]) and (ii) creation of an H. pylori library of genomic promoters fused to the tnpR gene (pcat-T-lib-tnpR). When tnpR expression was directed by the cloned H. pylori DNA, TnpR bound the res1 sequences and catalyzed the removal of the intervening Kmr cassette (Fig. 1).

We changed the original RIVET system from a V. cholerae-specific antibiotic resistance (tetracycline) system to a system that works with H. pylori. To do this, we chose a Kmr gene (aphA3 or Km) that carries its own promoter and flanked it with recombinase recognition sequences (res1) to create res1-Km-res1. We used the mutant res sequence res1, which contains a mutation at the crossover site resulting in decreased recombination efficiency (59). We hypothesized that use of the res1 allele would allow us to identify promoters that were expressed to some extent in vitro but exhibited elevated expression in the host. The res1-Km-res1 cassette was cloned into a plasmid that directed its integration into the chromosomal region between open reading frames HP0294 and HP0295 (19). We integrated this construct into the chromosome of H. pylori strain mG27 to ensure that a single copy was present and to ensure that it was stably maintained. H. pylori strain mG27 is a mouse-adapted version of the commonly used H. pylori strain G27 (19, 79). Integration at the HP0294-HP0295 site occurred by double-crossover gene replacement and did not affect the growth or virulence of H. pylori strains mG27 and SS1 (data not shown). We verified that res1-Km-res1 integrated into the proper chromosomal region by selecting for Kmr transformants and by performing PCR with oligonucleotide primers that flanked the insertion site (data not shown). The resulting strain was designated ACHP17 (Table 1).

Generating the library of potential promoters (pcat-T-lib-tnpR). To generate pcat-T-lib-tnpR (Table 1), we created a plasmid with a promoterless tnpR gene and cloned a partially Sau3A-digested H. pylori genomic library upstream of tnpR (Fig. 2A). The plasmid contained the cat gene, which conferred Cmr, followed by a strong E. coli terminator, the site for H. pylori library insertion, and the promoterless tnpR gene, all flanked by sequences of the H. pylori gene rdxA. Expression of the cat gene is directed by its endogenous promoter, and the E. coli terminator prevents read-through transcription of tnpR (19). We used the wild-type tnpR allele, which had a wild-type ribosome binding site, for our work (48). pcat-T-lib-tnpR was a collection of ~12,000 independent colonies. Our analysis of 30 library clones suggested that 70% of them contained inserts with an average size of 1.0 kb (data not shown). Our analysis also indicated that the library was diverse and covered the 1.8-Mb H. pylori genome 4.7 times (see Materials and Methods). The rdxA sequences flanking cat-T-lib-tnpR in pcat-T-lib-tnpR targeted integration of this plasmid into the H. pylori chromosomal rdxA locus by double-crossover homologous recombination (Fig. 2B). The rdxA locus is commonly used for integrating exogenous DNA into the H. pylori chromosome (80).

Creation of the H. pylori RIVET library. To construct the H. pylori RIVET library strains, pcat-T-lib-tnpR was used to transform H. pylori strain ACHP17 (HP0294/HP0295::res1-Km-res1) (Table 1) to Cmr (Fig. 2B). Each Cmr transformant was passaged twice in Cm-containing media before selection on Km-containing media and subsequent freezing. We initially passaged the Cmr transformants without Km selection to allow promoters that were expressed in the lab to convert the strains carrying them to Kms (Fig. 2C). We were interested in promoters that were not expressed in the lab or were expressed at very low levels in the lab and thus in bacteria that retained Kmr (res1-Km-res1). The genomic DNA of 30 Cmr H. pylori transformants was screened by PCR using oligonucleotides that annealed upstream and downstream of the genomic DNA fragment to assess whether this subset of transformants contained unique genomic DNA inserts upstream of tnpR. The results of our screening of the H. pylori transformants suggested that 70% of them contained unique inserts and that the inserts were smaller (0.65 kb) than those found for the same library in E. coli. Although we are not certain, we speculate that the average insert size in the H. pylori RIVET library was smaller than the average insert size in pcat-T-lib-tnpR either because the larger inserts had more potential sites for H. pylori's restriction systems or because larger inserts recombined less efficiently. Our H. pylori RIVET library contained 3,340 independent clones that were pooled in groups of 10 and stored in H. pylori freezing media at –80°C. These transformants covered ~84% of the H. pylori genome (see Materials and Methods).

Identifying H. pylori host-induced promoters. To identify putative host-induced promoters, we used the H. pylori RIVET library strains to infect FVB/N mice (Fig. 2D). We screened 50 H. pylori RIVET library strains in parallel by infecting mice with a mixture of 50 RIVET library strains. Baldwin and coworkers showed that this pool size allows each strain to independently establish an infection in the mouse gastric mucosa (6). The infections were allowed to persist for 2 weeks, and then we sacrificed the animals and harvested their stomachs. The stomachs were homogenized, diluted, and plated on Cm-containing media. After 4 days, each plate was replica plated on both Cm-containing media and Km-containing media (Fig. 2D). RIVET strains that induced tnpR expression at any time during the infection converted to Kms. The Kms strains were rescued from the corresponding Cm-containing plates and saved as frozen stocks for additional analysis. We screened 2,960 clones of our 3,340-clone H. pylori RIVET library and thus approximately 74% of the H. pylori genome. Our screening analysis resulted in identification of 113 Kms H. pylori RIVET strains. By using PCR amplification and sequencing of the region cloned upstream of tnpR in these strains, we determined that the 113 Kms strains represented 13 unique clones (see Table S1 in the supplemental material). We designated these unique clones Pivi clones and the strains containing them ivi strains; to identify a specific clone or strain, the number corresponding to the order of ivi strain isolation was added to its designation (Table 1).

Verifying that the Pivi clones were induced in the host. We retested the Pivi clones identified as described above to ensure that their expression in mice was greater than their expression in vitro. The ivi strains, which were isolated from mouse stomachs as Kms strains, induced tnpR expression in vivo and thus removed the res1-Km-res1 cassette from the H. pylori chromosome. Therefore, we reintroduced res1-Km-res1 into these strains by transforming them to Kmr with the construct used to create the original strain (pAW2rkr2) (see Materials and Methods). Strains containing 1 of the 13 Pivi clones fused upstream of tnpR and the res1-Km-res1 cassette (reconstructed ivi strains) were designated by adding R to the end of the ivi designation and were analyzed further to examine promoter-directed expression of tnpR based on their conversion from Kmr to Kms (Table 1).

To determine Pivi-directed expression of tnpR in the host, we infected mice with each reconstructed ivi strain as a single infecting strain. Each infection was allowed to persist for 2 weeks, and then we sacrificed the animals, harvested their stomachs, and plated the stomachs to obtain single colonies on Cm-containing media as described above. Plates containing the colonies isolated from stomachs were then replica plated on Cm-containing media and Km-containing media. The level of promoter induction in vivo (expressed as a percentage) was determined by dividing the number of Kms colonies by the total number of colonies analyzed and multiplying the result by 100. To determine the in vitro expression conferred by each Pivi clone, each reconstructed ivi strain was passaged on Cm-containing media in the lab for 2 weeks (four or five passages) and then plated on Cm-containing media to obtain single colonies. The resulting plates were replica plated on both Cm-containing media and Km-containing media to determine the level of promoter induction in vitro.

We found that 4 of the 13 Pivi clones originally isolated from mice as Kms ivi strains conferred in vivo expression of tnpR that was significantly higher than the in vitro expression when the strains were tested as single infecting strains (as determined by two-tailed Student's t test) (Fig. 3). These Pivi clones were Pivi51 (P < 0.001), Pivi66 (P < 0.001), Pivi70 (P < 0.05), and Pivi77 (P < 0.05). The values for two additional Pivi clones, Pivi10 and Pivi67, were very close to our cutoff for statistical significance, with P values of <0.1. We included these six Pivi clones in our subsequent analyses. The remaining seven Pivi clones identified in our screen as Kms ivi strains did not show in vivo induction of tnpR when they were retested as single infecting strains (Fig. 3). It is possible that the Pivi clones either were simply not induced in mice and were isolated as background clones inherent in this screen or were induced only when the strains were used in coinfections with additional strains, as was done in the screening of our H. pylori RIVET library. Alternatively, retesting of only one Kms colony for each unique Pivi clone could have contributed to a high false-negative rate. We did not perform additional studies to distinguish between these possibilities.


Figure 3
View larger version (22K):
[in this window]
[in a new window]

  		FIG. 3. Six RIVET-identified promoters were induced in the host. The relative level of promoter induction of each of the 13 reconstructed RIVET strains isolated from mice as Kms strains was analyzed both in mice and in the lab. Promoter induction in the host was analyzed using each reconstructed RIVET strain to independently infect a group of mice for 2 weeks. Promoter induction in the lab was analyzed after 2 weeks of in vitro growth on CHBA. For both in vivo and in vitro experiments, the level of promoter induction was calculated by dividing the number of Kms CFU isolated by the total number of CFU and multiplying the result by 100. All promoters indicated by an asterisk were induced to a greater extent in vivo than in vitro. A two-tailed Student t test was used to determine the following P values for the promoters when in vitro induction and in vivo induction were compared: for Pivi10, <0.1; for Pivi51, <0.001; for Pivi66, <0.001; for Pivi67, <0.1; for Pivi70, <0.05; and for Pivi77, <0.05. The other promoters did not differ appreciably under in vivo and in vitro conditions. The error bars indicate standard deviations. For the RIVET strains, the in vitro experiment was replicated two to six times and the in vivo analysis was carried out using zero to nine mice, as follows: for Pivi2, two in vitro replicates and five mice; for Pivi7, three in vitro replicates and five mice; for Pivi10, three in vitro replicates and four mice; for Pivi11, two in vitro replicates and one mouse; for Pivi23, three in vitro replicates and nine mice; for Pivi39, six in vitro replicates and no mice; for Pivi50, one in vitro replicate and two mice; for Pivi51, four in vitro replicates and nine mice; for Pivi63, two in vitro replicates and two mice; for Pivi66, six in vitro replicates and three mice; for Pivi67, two in vitro replicates and three mice; for Pivi70, two in vitro replicates and four mice; and for Pivi77, four in vitro replicates and three mice.

Genomic location of in vivo-induced promoters. We modified the RIVET system for use with H. pylori so that it identified in vivo-induced promoters instead of specific in vivo-induced genes. Thus, we were interested in determining the genes regulated by our in vivo-induced promoters. To identify these genes, we mapped the genomic locations of the six Pivi clones on the H. pylori genome by comparing their sequences to the sequence of the H. pylori strain G27 genome (Fig. 4 and unpublished data). The locations of the Pivi clones in the G27 genome were the same as those in the previously described H. pylori genomes with the exception of the location of Pivi10, which is located on an endogenous plasmid (1, 61, 85). Therefore, we used H. pylori strain 26695 annotation for all Pivi clones except Pivi10 (85). The gene(s) regulated by each Pivi clone is discussed below.


Figure 4
View larger version (12K):
[in this window]
[in a new window]

  		FIG. 4. Locations of in vivo-induced promoters on the H. pylori chromosome or an endogenous plasmid. Each in vivo-induced promoter is represented by an open box, and the arrow below the box indicates the direction in which the promoter was cloned. The open reading frames overlapped by and in the genomic region of the in vivo-induced promoters are indicated by thick arrows. (A) Pivi10 is 153 bp long and overlaps the mobC gene in the H. pylori strain mG27 endogenous plasmid. It likely regulates mobA, mobB, and mobD. (B) Pivi51 is 95 bp long and overlaps mesJ and the intergenic region upstream of mesJ and thus likely regulates mesJ. (C) Pivi66 is 166 bp long and is located within cagY, upstream of a putative operon containing cagZ, virB11, and virD4. (D) Pivi67 is 133 bp long and overlaps HP1359, ubiA, and the intergenic region between them. There are six genes that are potentially regulated by Pivi67, including three uncharacterized open reading frames (HP1359, HP1358, and HP1354) psd, nadA, and nadC. (E) Pivi70 is 119 bp long and is located within HP0286. Pivi70 potentially regulates the metalloprotease gene ftsH and uncharacterized open reading frames HP0287 and HP0288. (F) Pivi77 is 1,679 bp long and overlaps HP0288, HP0289, and the intergenic region between them. Pivi77 likely regulates the vacA paralogue encoded by HP0289.

Pivi clones regulating H. pylori genes involved in interactions with other cells. Three of the Pivi clones were located in DNA regions upstream of a gene or set of genes potentially used by H. pylori to interact with other bacterial cells or with host cells. Pivi10 was located in the putative mobC gene upstream of the putative mobA, mobB, and mobD genes on an endogenous H. pylori strain G27 plasmid (Fig. 4). About 50% of H. pylori strains harbor endogenous plasmids (69), and plasmid DNA would have been isolated by our genomic DNA preparation procedure and thus included in our pcat-T-lib-tnpR and H. pylori RIVET libraries. mob genes encode relaxosome components required for plasmid nicking and mobilization during horizontal gene transfer (32). Pivi66 mapped to the CAG pathogenicity island in the cagY gene upstream of a predicted operon containing cagZ, virB11, and virD4. The CAG pathogenicity island is a 40-kb region containing ~30 genes, and its presence is associated with H. pylori infections that have more severe disease outcomes (21). Some of the gene products encoded by the CAG pathogenicity island form a type IV secretion apparatus known to inject at least two effectors, CagA and peptidoglycan, into host cells (5, 88). While VirD4 and VirB11 are homologues of an adapter protein likely involved in substrate export (2, 85) and an ATPase that generates energy for apparatus assembly and substrate export (77, 85), respectively, the function of CagZ is not known yet. Finally, Pivi77 overlapped the intergenic region upstream of one of the uncharacterized vacA paralogues, HP0289 (85). vacA encodes a well-characterized cytotoxic vacuolating protein belonging to the autotransporter family and is required by H. pylori for full virulence (72, 90). The similarity of the HP0289 protein to VacA is concentrated mostly in the carboxy-terminal autotransporter domain rather than in the cytotoxic vacuolating amino-terminal domain (55), and it is therefore not clear what role the HP0289 protein may play in H. pylori virulence.

Pivi51 regulates the putative mesJ lysidine synthetase. Pivi51 overlaps mesJ and the upstream intergenic region and therefore likely regulates mesJ. mesJ, also called tilS in E. coli, is a member of the PP-loop ATPase superfamily. Members of this superfamily of proteins have distinct enzymatic functions but share an ATP pyrophosphatase domain that targets the alpha-beta bond of ATP (13). Recently, tilS was found to govern both the codon and amino acid specificities of the isoleucine tRNA (81). TilS is a lysidine synthetase that generates the lysidine modification at the wobble position of the tRNAIle anticodon. This changes the codon specificity from AUG to AUA and the amino acid specificity from methionine to isoleucine (81).

Pivi70 regulates a putative metalloprotease. Another of the in vivo-induced promoters, Pivi70, was located in open reading frame HP0285, upstream of the H. pylori ftsH gene and two hypothetical open reading frames, HP0287 and HP0288. ftsH (HP0286) encodes a putative ATP-dependent metalloprotease (33) and is essential for growth in E. coli. In E. coli this integral inner membrane metalloprotease degrades both cytosolic proteins, including sigma 32 and lambda CII (36, 37), and transmembrane proteins, including SecY and YccA (43, 44). FtsH likely plays a role in cell division as an E. coli strain with a temperature-sensitive ftsH allele exhibits filamentous growth at restrictive temperatures (74). Two ftsH homologues, HP0286 and HP1069, are present in H. pylori; Ge and Taylor (33) showed that HP1069 is essential. There have been no studies to date of HP0286-encoded FstH, and H. pylori FtsH targets have not been identified yet. The products of HP0287 and HP0288, which are two hypothetical open reading frames located downstream of fstH, show no homology to previously identified proteins (85).

Pivi67 regulates previously uncharacterized proteins. Pivi67, the last of the in vivo-induced promoters identified in our analysis, was located upstream of six open reading frames predicted to be in the same operon. These open reading frames included two hypothetical open reading frames, HP1359 and HP1358, followed by psd (encoding a phosphatidyl serine decarboxylase), nadA (encoding a quinolinate synthetase A), nadC (encoding a nicotinate dinucleotide pyrophosphorylase), and an open reading frame encoding a putative adenine-specific methyltransferase.

Genes regulated by Pivi clones play a role in H. pylori colonization of the host. To address our goal of identifying H. pylori genes required for host colonization and/or disease development, we created deletion mutants with mutations in genes potentially regulated by our Pivi clones and analyzed these mutants to determine mouse colonization phenotypes. When there was more than one gene potentially regulated by our Pivi clones, we attempted to construct a mutant with a deletion of the gene immediately downstream of the promoter. Thus, we created mutants with deletions of the mobA and cagZ genes, which were immediately downstream of Pivi10 and Pivi66, respectively. However, since the mobB and mobD open reading frames are located in the mobA open reading frame, we actually created a mobABD triple-deletion strain. Several unsuccessful attempts were made to delete HP1359, the hypothetical open reading frame downstream of Pivi67, and ftsH, the metalloprotease gene downstream of Pivi70. Our inability to delete these genes is consistent with the hypothesis that they are essential for viability, as proposed by other workers (73). Finally, we did not analyze HP0289 and mesJ, the open reading frames downstream of Pivi77 and Pivi51, respectively.

H. pylori nonpolar deletion mutants were constructed by replacing the open reading frame of interest with the cat gene, which conferred Cmr (see Materials and Methods). Deletion and insertion cassettes were generated using a sewing PCR strategy described by Chalker et al. (22) that allows efficient gene deletion and replacement with a cat gene. The cagZ gene was deleted in the H. pylori SS1 strain commonly used for analyzing H. pylori phenotypes in mice because this strain reproducibly infects mice. To address the possibility that cagZ is differently regulated in the SS1 strain, we verified that the promoter regulating cagZ was similarly induced in the mG27 and SS1 strains, i.e., 77.3 and 76%, respectively (Fig. 3). The mobABD genes were deleted in mG27 since we knew that this strain contains the endogenous plasmid from which Pivi10 was isolated. mG27 infects mice at levels that are approximately 10-fold less than the H. pylori SS1 strain levels. In each case, Cmr transformants were selected and analyzed by PCR to verify deletion of the cagZ and mobABD loci. Deletion of cagZ and mobABD were unlikely to have polar effects on downstream genes, as we verified expression of the gene downstream of cagZ in the {Delta}cagZ strain by reverse transcription-PCR (data not shown) and there is a putative transcriptional terminator downstream of mobABD (38). Finally, deletion of mobABD and deletion of cagZ did not confer in vitro growth defects when we used the mutant strains in in vitro competition assays with the wild-type mG27 and SS1 strains, respectively (Table 3).


View this table:
[in this window]
[in a new window]

  		TABLE 3. In vitro growth competition between the mobABD and cagZ mutants and the correspoding isogenic wild-type strains

To assess the contribution of cagZ and mobABD to H. pylori colonization of mice, we carried out both single-strain infection studies and coinfection studies. For single-strain infection studies we infected groups of five mice with each mutant strain ({Delta}cagZ or {Delta}mobABD) and each wild-type strain (SS1 or mG27). For the coinfection studies a mutant strain ({Delta}cagZ or {Delta}mobABD) was used to infect a group of five mice along with the wild-type passage control strain (SS1 and mG27, respectively). Single-strain studies and coinfection studies for each mutant-wild-type strain pair were carried out simultaneously using the same mutant strain and wild-type strain inocula so we could be confident of the mutant strain behavior in the coinfection study.

When it was used as the only infecting strain, the {Delta}cagZ strain had a colonization fitness similar to that of the wild-type strain (Fig. 5). Interestingly, however, when mice were infected with the {Delta}cagZ strain along with the wild-type strain, the {Delta}cagZ strain outcompeted the wild-type strain; no wild-type cells or a reduced number of wild-type cells were isolated from the stomachs of mice coinfected with the wild-type and {Delta}cagZ strains (Fig. 5 and data not shown). We calculated that the competitive indices were 5,713 for one coinfection experiment (Fig. 5) and 20 for a second coinfection experiment. These competitive indices suggest that the {Delta}cagZ strain outcompetes the wild-type strain in mice by approximately 1 to 3 orders of magnitude. These results intriguingly suggest that elevated transcription of cagZ in mice actually decreases the bacterium's colonization ability, and they are consistent with the notion that genes identified by our RIVET analysis play roles in host colonization.


Figure 5
View larger version (16K):
[in this window]
[in a new window]

  		FIG. 5. The {Delta}cagZ H. pylori mutant outcompetes the wild-type strain in a coinfection colonization assay. Single-strain infection and coinfection studies with H. pylori {Delta}cagZ and wild-type strains were carried out using FVB/N mice for 2 weeks as described in Materials and Methods. The results of one representative set of experiments are shown. Each point represents one mouse stomach, and the solid lines indicate the averages. When the {Delta}cagZ mutant strain was coinfected with the wild-type strain, we were unable to detect any wild-type strain and thus placed its concentration at the limit of detection (200 CFU/g). This suggests that the {Delta}cagZ mutant strain outcompeted the wild-type strain for colonization (competitive index, 5,713).

When the {Delta}mobABD strain was used as the only infecting strain in mice, overall it infected the animals less well than the wild-type strain (Fig. 6). Only three of the five mice treated with the {Delta}mobABD strain became infected, and the mice that were infected had a bacterial stomach load (CFU/g) that was about 0.5 log lower than that of mice infected with the wild-type strain. Consistent with this defect, the {Delta}mobABD mutant strain was not detected in plates containing stomachs of mice coinfected with the {Delta}mobABD mutant and wild-type H. pylori strains (competitive index, 0.007). Since the {Delta}mobABD strain performed like the wild-type strain in in vitro growth and competition studies (Table 3), these results suggest that the MobABD proteins are important for promoting stomach colonization. However, complementation studies in which we reintroduced the mobABD and cagZ genes into our {Delta}mobABD and {Delta}cagZ mutant strains, respectively, are required to be certain that these genes are responsible for the stomach colonization phenotypes, although these mutant strains had no other detectable defects (see Materials and Methods).


Figure 6
View larger version (16K):
[in this window]
[in a new window]

  		FIG. 6. The {Delta}mobABD H. pylori mutant is defective for host colonization. Single-strain infection and coinfection studies with H. pylori {Delta}mobABD and wild-type strains were carried out using FVB/N mice for 2 weeks. Each point represents one mouse stomach, and the solid lines indicate the averages. The {Delta}mobABD mutant was not recovered from stomach plates prepared for mice coinfected with both the {Delta}mobABD mutant and wild-type strain, indicating that it was outcompeted by the wild-type strain (competitive index, 0.007).


arrow
DISCUSSION
 
In this study, we used RIVET with H. pylori and identified six promoters that are induced in response to murine host stomachs. We created deletions in two of the genes putatively regulated by these in vivo-induced promoters and found that they are important for host colonization. The {Delta}mobABD mutant strain was defective for host colonization in both single-infection and coinfection studies, and interestingly, the {Delta}cagZ mutant strain outcompeted the wild-type control strain in coinfection studies. Our findings support the hypothesis that H. pylori factors important for colonization can be successfully identified as in vivo-induced genes using the RIVET system.

RIVET analysis of H. pylori. RIVET has proven to be a valuable tool for identifying bacterial genes important for growth in specific niches, such as inside a host (14, 18, 51, 76, 87). The use of RIVET in this study was the first time that a screen of this kind has been done with H. pylori. The advantage of RIVET over other in vivo expression technology systems is that it detects transient gene induction in a small number of cells. RIVET also allows identification of niche-regulated genes expressed at different levels (18, 63). In our RIVET analysis, we combined the tnpR allele with a wild-type ribosome-binding site and the res1 allele, which was recombined with 10-fold-reduced efficiency compared to the wild-type res allele (48, 59). This combination was used to identify H. pylori genes that were expressed in the lab, induced in the mouse stomach environment, and are important for mouse colonization.

RIVET identifies novel and previously identified host-induced genes. Several previous studies identified H. pylori host-induced genes with the goal of finding candidate colonization and disease-promoting factors (11, 12, 34, 45, 78). These studies were carried out both in vivo using humans, Rhesus macaques, and Mongolian gerbils and in vitro using a gastric epithelial cell line (11, 12, 34, 45, 78). Only our Pivi66 promoter was also identified by these studies. Pivi66 maps to the CAG pathogenicity island and regulates a predicted operon including HP0524 (virD4), HP0525 (virB11), and HP0526 (cagZ). HP0524 is induced in the Rhesus macaque infection model, and HP0525 is induced in both the Rhesus macaque and Mongolian gerbil infection models (11, 78). This small overlap in the identification of host-induced genes between RIVET and previous studies both validates the RIVET method and highlights the conclusion that RIVET identified a set of unique host-induced genes.

Pivi66 regulates CAG pathogenicity island genes. Pivi66 putatively regulates a set of three genes, HP0524 (virD4), HP0525 (virB11), and HP0526 (cagZ), that are located in the H. pylori CAG pathogenicity island. Most of the genes in the CAG pathogenicity island, including virD4, virB11, and cagZ, have been analyzed to examine their roles in host colonization, interleukin-8 (IL-8) induction, and CagA transport (30). Interestingly, although virD4, virB11, and cagZ are predicted to be in an operon, their contribution to cag pilus function and mouse colonization appears to be distinct. VirD4 is not required for IL-8 induction, but it is important for CagA transport into gastric epithelial cells (30). VirB11 is important for both IL-8 induction and CagA transport into gastric epithelial cells. CagZ contributes to both cag functions as the {Delta}cagZ strain induces IL-8 and transports CagA at reduced levels compared to wild-type H. pylori strains (30). Both the {Delta}virD4 and {Delta}virB11 mutant H. pylori strains were attenuated for mouse colonization in single-infection studies, while the {Delta}cagZ strain infected mice at levels similar to the levels of infection of the wild-type strain in single-strain infection studies (56; this study). We observed, however, that the {Delta}cagZ strain had a colonization advantage during coinfection. It is not clear that the reduced cag function of the {Delta}cagZ mutant is responsible for the enhanced colonization phenotype that we observed.

The crystal structure and protein interaction profile of CagZ are consistent with a chaperonelike function for CagZ (20), because of the presence of a disordered carboxy-terminal tail and a highly negatively charged surface. Members of a class of chaperones important for delivery of type III effectors, including CesT from enterohemorrhagic E. coli and SigE from Salmonella spp., have a unique structure, but they also have negatively charged surfaces (52). It is possible that CagZ contributes directly to the transport of the CagA effector; however, since CagZ is not absolutely required for CagA transport, this seems unlikely. Another possibility is that CagZ has a chaperonelike function for assembly of the cag secretion pilus. In fact, CagZ was found to interact with 10 Cag proteins (CagY, CagX, CagV, CagT, CagS, CagM, CagI, CagG, CagF, and CagE) in yeast two-hybrid and coimmunoprecipitation studies (16). Many of these proteins form the channel or core of the cag pilus structure (4). We hypothesize that CagZ may in fact provide chaperone activity and help assemble antigens, similar to the role proposed for CagY (70). If this prediction is correct, cagZ mutants would have less CAG pilus antigenicity and might have been able to avoid an anti-CAG immune response that would have targeted the wild-type strain. Such immune avoidance could have conferred the enhanced colonization phenotype. Future Cag protein assembly experiments with a {Delta}cagZ strain will address this hypothesis.

In vivo-induced promoter regulates genes with putative roles in horizontal gene transfer. DNA transfer via conjugation is a common mechanism for sharing genetic material that can contribute to the success of pathogenic bacteria (26). Conjugation is the transfer of DNA from a bacterial donor to a recipient cell by direct cell-to-cell contact. We identified a group of H. pylori endogenous plasmid-borne genes, mobA, mobB, and mobD, as genes that are induced during mouse infection and are important for mouse colonization. The mob genes have been shown to be important for DNA transfer via conjugation in other microbes. The mob genes encode a relaxase (mobA) and accessory proteins (mob and mobD) that make up a complex called the relaxosome. The relaxosome functions by (i) nicking the DNA molecule to be transferred at the origin of transfer, (ii) becoming covalently associated with the 5' end of the single-stranded DNA, (iii) transporting the DNA molecule to the conjugation machinery at the inner cell membrane via a coupling protein, and (iv) transporting the DNA molecule across the bacterial membranes through the conjugation machinery into the recipient cell (49). The other components important for DNA transfer via conjugation include the coupling protein mentioned above, the transmembrane protein complex, and the conjugation pilus (7, 50). DNA transfer via conjugation is a widespread method of horizontal gene transfer in the prokaryotic world and has been documented to occur between prokaryotes and eukaryotes as well, including yeast, plant, and mammalian cells (15, 46, 89, 92).

DNA transfer via conjugation has been shown to occur between H. pylori clinical isolates and between H. pylori and Campylobacter jejuni (3, 65). Specific conjugation component homologues have been identified in H. pylori, including two chromosomally encoded relaxase proteins, Rlx1 and Rlx2, and two chromosomally encoded coupling proteins, TraG and VirD4 (3). Only Rlx1 and TraG, however, are important for DNA transfer via conjugation (3). Also present in H. pylori are three systems ancestrally related to conjugation machinery, including the cag, comB, and tfs3 type IV secretions systems (24, 39, 42). Interestingly, none of these three systems appears to be important for conjugation (3). The role of conjugation in H. pylori infection biology is not clear yet, however. About 30% of the H. pylori clinical isolates characterized contain the mob region (38), and it is possible that the mobA-encoded relaxase is important for initiating plasmid transfer in some H. pylori strains.

In vivo-induced promoter regulates a vacA paralogue. Three vacA paralogues are present in each of the three published H. pylori genomes (the H. pylori 26695, J99, and HPAG1 genomes) and in our unpublished genome for the G27 strain (1, 61, 85). The amino termini of the proteins encoded by the vacA paralogues (the HP0289, HP0610, and HP0922 proteins) are not well conserved among the paralogues, and each paralogue is not well conserved among the sequenced H. pylori strains (1, 61, 85). Like VacA, these proteins belong to the autotransporter protein family based on primary sequence homology. Autotransporters are characterized by three domains, (i) a sec signal peptide for transport across the cytoplasmic membrane, (ii) an amino terminus that confers a unique catalytic function, and (iii) a β domain that forms a porelike structure in the outer membrane and transports the amino terminus across the outer membrane. The amino-terminal domain then either remains associated with the outer membrane or is cleaved and secreted, as observed for VacA (29). Most of the homology between the vacA paralogues and vacA is in the sequences encoding the carboxy-terminal β domains. The HP0289, HP0610, and HP0922 proteins are therefore unlikely to have the same cytotoxic activity as VacA. Based on their primary sequences, these proteins also lack the cleavage site that would suggest that they are secreted into the extracellular milieu (85).

Although the function of the vacA paralogues in H. pylori virulence is not evident from their primary sequences, recent studies have suggested that they are important for colonization. The identification of HP0289 in a signature-tagged mutagenesis screen for gerbil colonization mutants suggests that HP0289 has a role in colonization (41). Another of the vacA paralogues, HP0610, was also found to be important for colonization in a murine model (6). The fact that the third vacA paralogue, HP0922, was not identified by either of these screens may indicate that it is not important for animal colonization, but it more likely reflects the difficulty of generating completely saturating screens for H. pylori. Additionally, future analyses of the sequences encoding amino-terminal passenger domains of the vacA paralogues may reveal their contributions to host colonization.

In vivo-induced promoters regulate essential genes. Three of the in vivo-induced promoters identified in this analysis regulate H. pylori genes that are likely essential for in vitro growth. Our unsuccessful attempts to create deletions in HP1359 and ftsH found downstream of Pivi67 and Pivi70, respectively, suggest that these genes are essential, as proposed by other workers (73). Although analysis of essential genes to determine their contributions to H. pylori colonization and virulence poses a unique set of challenges, these genes may produce a novel set of H. pylori virulence factors. The recent development of an inducible gene expression system for H. pylori should expedite the study of these essential genes (10).

In summary, development and use of RIVET for H. pylori identified six sets of genes, two of which are important in animal colonization, as shown here. Further, the development of RIVET for H. pylori should provide powerful tools for studying H. pylori gene expression and gene regulation in the host environment.


arrow
ACKNOWLEDGMENTS
 
We acknowledge Andrew Lowenthal, Edward Cabral, and Daryl Strano for their technical contributions. We thank Andrew Camilli for providing RIVET plasmids, Nigel Grindley for providing anti-TnpR antibody, and Susan Williams for helpful discussions.

This work was supported by research scholar grant RSG-05-249-01-MBC from the American Cancer Society to K.M.O.


arrow
FOOTNOTES
 
* Corresponding author. Present address for Andrea A. Castillo: Department of Biology, Eastern Washington University, Cheney, WA 99004. Phone: (509) 359-2866. Fax: (509) 359-6867. E-mail: acastillo{at}mail.ewu.edu. Mailing address for Karen M. Ottemann: Department of Environmental Toxicology, University of California, Santa Cruz, 1156 High St., Santa Cruz, CA 95064. Phone: (831) 459-4780. Fax: (831) 459-3524. E-mail: ottemann{at}etox.ucsc.edu Back

{triangledown} Published ahead of print on 15 September 2008. Back

{dagger} Supplemental material for this article may be found at http://iai.asm.org/. Back

Editor: B. A. McCormick

{ddagger} Present address: Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, San Francisco, CA 94143. Back


arrow
REFERENCES
 
    1
  1. Alm, R. A., L.-S. L. Ling, D. T. Moir, B. L. King, E. D. Brown, P. C. Doig, D. R. Smith, B. Noonan, B. C. Guild, B. L. Dejonge, G. Carmel, P. J. Tummino, A. Caruso, M. Uria-Nickelsen, D. M. Mills, C. Ives, R. Gibson, D. Merber, S. D. Mills, Q. Jiang, D. E. Taylor, G. F. Vovis, and T. J. Trust. 1999. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397:176-180.[CrossRef][Medline]
    2. 2
  2. Atmakuri, K., E. Cascales, and P. J. Christie. 2004. Energetic components VirD4, VirB11 and VirB4 mediate early DNA transfer reactions required for bacterial type IV secretion. Mol. Microbiol. 54:1199-1211.[CrossRef][Medline]
    3. 2a
  3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1990. Current protocols in molecular biology, vol. 1. John Wiley and Sons, Inc., New York, NY.
    4. 3
  4. Backert, S., T. Kwok, and W. Konig. 2005. Conjugative plasmid DNA transfer in Helicobacter pylori mediated by chromosomally encoded relaxase and TraG-like proteins. Microbiology 151:3493-3503.[Abstract/Free Full Text]
    5. 4
  5. Backert, S., and T. F. Meyer. 2006. Type IV secretion systems and their effectors in bacterial pathogenesis. Curr. Opin. Microbiol. 9:207-217.[CrossRef][Medline]
    6. 5
  6. Backert, S., E. Ziska, V. Brinkmann, U. Zimny-Arndt, A. Fauconnier, P. R. Jungblut, M. Naumann, and T. F. Meyer. 2000. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell. Microbiol. 2:155-164.[CrossRef][Medline]
    7. 6
  7. Baldwin, D. N., B. Shepherd, P. Kraemer, M. K. Hall, L. K. Sycuro, D. M. Pinto-Santini, and N. R. Salama. 2007. Identification of Helicobacter pylori genes that contribute to stomach colonization. Infect. Immun. 75:1005-1016.[Abstract/Free Full Text]
    8. 7
  8. Baron, C., D. O'Callaghan, and E. Lanka. 2002. Bacterial secrets of secretion: EuroConference on the biology of type IV secretion processes. Mol. Microbiol. 43:1359-1365.[CrossRef][Medline]
    9. 8
  9. Blaser, M. J., and J. C. Atherton. 2004. Helicobacter pylori persistence: biology and disease. J. Clin. Investig. 113:321-333.[CrossRef][Medline]
    10. 9
  10. Blom, K., A. M. Svennerholm, and I. Bolin. 2002. The expression of the Helicobacter pylori genes ureA and nap is higher in vivo than in vitro as measured by quantitative competitive reverse transcriptase-PCR. FEMS Immunol. Med. Microbiol. 32:219-226.[CrossRef][Medline]
    11. 10
  11. Boneca, I. G., C. Ecobichon, C. Chaput, A. Mathieu, S. Guadagnini, M. C. Prevost, F. Colland, A. Labigne, and H. de Reuse. 2008. Development of inducible systems to engineer conditional mutants of essential genes of Helicobacter pylori. Appl. Environ. Microbiol. 74:2095-2102.[Abstract/Free Full Text]
    12. 11
  12. Boonjakuakul, J. K., D. R. Canfield, and J. V. Solnick. 2005. Comparison of Helicobacter pylori virulence gene expression in vitro and in the Rhesus macaque. Infect. Immun. 73:4895-4904.[Abstract/Free Full Text]
    13. 12
  13. Boonjakuakul, J. K., M. Syvanen, A. Suryaprasad, C. L. Bowlus, and J. V. Solnick. 2004. Transcription profile of Helicobacter pylori in the human stomach reflects its physiology in vivo. J. Infect. Dis. 190:946-956.[CrossRef][Medline]
    14. 13
  14. Bork, P., and E. V. Koonin. 1994. A P-loop-like motif in a widespread ATP pyrophosphatase domain: implications for the evolution of sequence motifs and enzyme activity. Proteins 20:347-355.[CrossRef][Medline]
    15. 14
  15. Bron, P. A., C. Grangette, A. Mercenier, W. M. de Vos, and M. Kleerebezem. 2004. Identification of Lactobacillus plantarum genes that are induced in the gastrointestinal tract of mice. J. Bacteriol. 186:5721-5729.[Abstract/Free Full Text]
    16. 15
  16. Bundock, P., A. den Dulk-Ras, A. Beijersbergen, and P. J. Hooykaas. 1995. Trans-kingdom T-DNA transfer from Agrobacterium tumefaciens to Saccharomyces cerevisiae. EMBO J. 14:3206-3214.[Medline]
    17. 16
  17. Busler, V. J., V. J. Torres, M. S. McClain, O. Tirado, D. B. Friedman, and T. L. Cover. 2006. Protein-protein interactions among Helicobacter pylori Cag proteins. J. Bacteriol. 188:4787-4800.[Abstract/Free Full Text]
    18. 17
  18. Camilli, A., D. T. Beattie, and J. J. Mekalanos. 1994. Use of genetic recombination as a reporter of gene expression. Proc. Natl. Acad. Sci. USA 91:2634-2638.[Abstract/Free Full Text]
    19. 18
  19. Camilli, A., and J. J. Mekalanos. 1995. Use of recombinase gene fusions to identify Vibrio cholerae genes induced during infection. Mol. Microbiol. 18:671-683.[CrossRef][Medline]
    20. 19
  20. Castillo, A. R., S. S. Arevalo, A. J. Woodruff, and K. M. Ottemann. 2008. Experimental analysis of Helicobacter pylori transcriptional terminators suggests this microbe uses both intrinsic and factor-dependent termination. Mol. Microbiol. 67:155-170.[Medline]
    21. 20
  21. Cendron, L., A. Seydel, A. Angelini, R. Battistutta, and G. Zanotti. 2004. Crystal structure of CagZ, a protein from the Helicobacter pylori pathogenicity island that encodes for a type IV secretion system. J. Mol. Biol. 340:881-889.[Medline]
    22. 21
  22. Censini, S., C. Lange, Z. Xiang, J. E. Crabtree, P. Ghiara, M. Borodovsky, R. Rappuoli, and A. Covacci. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93:14648-14653.[Abstract/Free Full Text]
    23. 22
  23. Chalker, A. F., H. W. Minehart, N. J. Hughes, K. K. Koretke, M. A. Lonetto, K. K. Brinkman, P. V. Warren, A. Lupas, M. J. Stanhope, J. R. Brown, and P. S. Hoffman. 2001. Systematic identification of selective essential genes in Helicobacter pylori by genome prioritization and allelic replacement mutagenesis. J. Bacteriol. 183:1259-1268.[Abstract/Free Full Text]
    24. 23
  24. Covacci, A., S. Censini, M. Bugnoli, R. Petracca, D. Burroni, G. Macchia, A. Massone, E. Papini, Z. Xiang, N. Figura, and R. Rappuoli. 1993. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA 90:5791-5795.[Abstract/Free Full Text]
    25. 24
  25. Covacci, A., and R. Rappuoli. 2000. Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell. J. Exp. Med. 191:587-592.[Free Full Text]
    26. 25
  26. Czajkowsky, D. M., H. Iwamoto, T. L. Cover, and Z. Shao. 1999. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. Proc. Natl. Acad. Sci. USA 96:2001-2006.[Abstract/Free Full Text]
    27. 26
  27. de la Cruz, F., and J. Davies. 2000. Horizontal gene transfer and the origin of species: lessons from bacteria. Trends Microbiol. 8:128-133.[CrossRef][Medline]
    28. 27
  28. Eaton, K. A., and S. Krakowka. 1992. Chronic active gastritis due to Helicobacter pylori in immunized gnotobiotic piglets. Gastroenterology 103:1580-1586.[Medline]
    29. 28
  29. Eaton, K. A., S. Suerbaum, C. Josenhans, and S. Krakowka. 1996. Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect. Immun. 64:2445-2448.[Abstract]
    30. 29
  30. Fischer, W., R. Buhrdorf, E. Gerland, and R. Haas. 2001. Outer membrane targeting of passenger proteins by the vacuolating cytotoxin autotransporter of Helicobacter pylori. Infect. Immun. 69:6769-6775.[Abstract/Free Full Text]
    31. 30
  31. Fischer, W., J. Puls, R. Buhrdorf, B. Gebert, S. Odenbreit, and R. Haas. 2001. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42:1337-1348.[CrossRef][Medline]
    32. 31
  32. Foynes, S., N. Dorrell, S. J. Ward, R. A. Stabler, A. A. McColm, A. N. Rycroft, and B. W. Wren. 2000. Helicobacter pylori possesses two CheY response regulators and a histidine kinase sensor, CheA, which are essential for chemotaxis and colonization of the gastric mucosa. Infect. Immun. 68:2016-2023.[Abstract/Free Full Text]
    33. 32
  33. Francia, M. V., A. Varsaki, M. P. Garcillan-Barcia, A. Latorre, C. Drainas, and F. de la Cruz. 2004. A classification scheme for mobilization regions of bacterial plasmids. FEMS Microbiol. Rev. 28:79-100.[CrossRef][Medline]
    34. 33
  34. Ge, Z., and D. E. Taylor. 1996. Sequencing, expression, and genetic characterization of the Helicobacter pylori ftsH gene encoding a protein homologous to members of a novel putative ATPase family. J. Bacteriol. 178:6151-6157.[Abstract/Free Full Text]
    35. 34
  35. Graham, J. E., R. M. Peek, Jr., U. Krishna, and T. L. Cover. 2002. Global analysis of Helicobacter pylori gene expression in human gastric mucosa. Gastroenterology 123:1637-1648.[CrossRef]
    36. 35
  36. Hatakeyama, M., and H. Higashi. 2005. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci. 96:835-843.[CrossRef][Medline]
    37. 36
  37. Herman, C., T. Ogura, T. Tomoyasu, S. Hiraga, Y. Akiyama, K. Ito, R. Thomas, R. D'Ari, and P. Bouloc. 1993. Cell growth and lambda phage development controlled by the same essential Escherichia coli gene, ftsH/hflB. Proc. Natl. Acad. Sci. USA 90:10861-10865.[Abstract/Free Full Text]
    38. 37
  38. Herman, C., D. Thevenet, R. D'Ari, and P. Bouloc. 1995. Degradation of sigma 32, the heat shock regulator in Escherichia coli, is governed by HflB. Proc. Natl. Acad. Sci. USA 92:3516-3520.[Abstract/Free Full Text]
    39. 38
  39. Hofreuter, D., and R. Haas. 2002. Characterization of two cryptic Helicobacter pylori plasmids: a putative source for horizontal gene transfer and gene shuffling. J. Bacteriol. 184:2755-2766.[Abstract/Free Full Text]
    40. 39
  40. Hofreuter, D., S. Odenbreit, and R. Haas. 2001. Natural transformation competence in Helicobacter pylori is mediated by the basic components of a type IV secretion system. Mol. Microbiol. 41:379-391.[CrossRef][Medline]
    41. 40
  41. Ilver, D., A. Arnqvist, J. Ogren, I. M. Frick, D. Kersulyte, E. T. Incecik, D. E. Berg, A. Covacci, L. Engstrand, and T. Borén. 1998. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279:373-377.[Abstract/Free Full Text]
    42. 41
  42. Kavermann, H., B. P. Burns, K. Angermüller, S. Odenbreit, W. Fischer, K. Melchers, and R. Haas. 2003. Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J. Exp. Med. 197:813-822.[Abstract/Free Full Text]
    43. 42
  43. Kersulyte, D., B. Velapatino, A. K. Mukhopadhyay, L. Cahuayme, A. Bussalleu, J. Combe, R. H. Gilman, and D. E. Berg. 2003. Cluster of type IV secretion genes in Helicobacter pylori's plasticity zone. J. Bacteriol. 185:3764-3772.[Abstract/Free Full Text]
    44. 43
  44. Kihara, A., Y. Akiyama, and K. Ito. 1998. Different pathways for protein degradation by the FtsH/HflKC membrane-embedded protease complex: an implication from the interference by a mutant form of a new substrate protein, YccA. J. Mol. Biol. 279:175-188.[CrossRef][Medline]
    45. 44
  45. Kihara, A., Y. Akiyama, and K. Ito. 1995. FtsH is required for proteolytic elimination of uncomplexed forms of SecY, an essential protein translocase subunit. Proc. Natl. Acad. Sci. USA 92:4532-4536.[Abstract/Free Full Text]
    46. 45
  46. Kim, N., E. A. Marcus, Y. Wen, D. L. Weeks, D. R. Scott, H. C. Jung, I. S. Song, and G. Sachs. 2004. Genes of Helicobacter pylori regulated by attachment to AGS cells. Infect. Immun. 72:2358-2368.[Abstract/Free Full Text]
    47. 46
  47. Lawley, T. D., W. A. Klimke, M. J. Gubbins, and L. S. Frost. 2003. F factor conjugation is a true type IV secretion system. FEMS Microbiol. Lett. 224:1-15.[CrossRef][Medline]
    48. 47
  48. Lee, A., J. O'Rourke, M. C. De Ungria, B. Robertson, G. Daskalopoulos, and M. F. Dixon. 1997. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112:1386-1397.[CrossRef][Medline]
    49. 48
  49. Lee, S. H., D. L. Hava, M. K. Waldor, and A. Camilli. 1999. Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection. Cell 99:625-634.[CrossRef][Medline]
    50. 49
  50. Llosa, M., and F. de la Cruz. 2005. Bacterial conjugation: a potential tool for genomic engineering. Res. Microbiol. 156:1-6.[Medline]
    51. 50
  51. Llosa, M., F. X. Gomis-Ruth, M. Coll, and F. de la Cruz Fd. 2002. Bacterial conjugation: a two-step mechanism for DNA transport. Mol. Microbiol. 45:1-8.[CrossRef][Medline]
    52. 51
  52. Lowe, A. M., D. T. Beattie, and R. L. Deresiewicz. 1998. Identification of novel staphylococcal virulence genes by in vivo expression technology. Mol. Microbiol. 27:967-976.[CrossRef][Medline]
    53. 52
  53. Luo, Y., M. G. Bertero, E. A. Frey, R. A. Pfuetzner, M. R. Wenk, L. Creagh, S. L. Marcus, D. Lim, F. Sicheri, C. Kay, C. Haynes, B. B. Finlay, and N. C. Strynadka. 2001. Structural and biochemical characterization of the type III secretion chaperones CesT and SigE. Nat. Struct. Biol. 8:1031-1036.[CrossRef][Medline]
    54. 53
  54. Mahan, M. J., J. M. Slauch, and J. J. Mekalanos. 1993. Selection of bacterial virulence genes that are specifically induced in host tissues. Science 259:686-688.[Abstract/Free Full Text]
    55. 54
  55. Mahdavi, J., B. Sonden, M. Hurtig, F. O. Olfat, L. Forsberg, N. Roche, J. Angstrom, T. Larsson, S. Teneberg, K. A. Karlsson, S. Altraja, T. Wadstrom, D. Kersulyte, D. E. Berg, A. Dubois, C. Petersson, K. E. Magnusson, T. Norberg, F. Lindh, B. B. Lundskog, A. Arnqvist, L. Hammarstrom, and T. Boren. 2002. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297:573-578.[Abstract/Free Full Text]
    56. 55
  56. Marais, A., G. L. Mendz, S. L. Hazell, and F. Megraud. 1999. Metabolism and genetics of Helicobacter pylori: the genome era. Microbiol. Mol. Biol. Rev. 63:642-674.[Abstract/Free Full Text]
    57. 56
  57. Marchetti, M., and R. Rappuoli. 2002. Isogenic mutants of the cag pathogenicity island of Helicobacter pylori in the mouse model of infection: effects on colonization efficiency. Microbiology 148:1447-1456.[Abstract/Free Full Text]
    58. 57
  58. Molinari, M., C. Galli, N. Norais, J. L. Telford, R. Rappuoli, J. P. Luzio, and C. Monticucco. 1997. Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers. J. Biol. Chem. 272:25339-25344.[Abstract/Free Full Text]
    59. 58
  59. Montecucco, C., and R. Rappuoli. 2001. Living dangerously: how Helicobacter pylori survives in the human stomach. Nat. Rev. Mol. Cell Biol. 2:457-466.[CrossRef][Medline]
    60. 59
  60. Newman, B. J., and N. D. Grindley. 1984. Mutants of the gamma delta resolvase: a genetic analysis of the recombination function. Cell 38:463-469.[CrossRef][Medline]
    61. 60
  61. Odenbreit, S., J. Puls, B. Sedlmaier, E. Gerland, W. Fischer, and R. Haas. 2000. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497-1500.[Abstract/Free Full Text]
    62. 61
  62. Oh, J. D., H. Kling-Backhed, M. Giannakis, J. Xu, R. S. Fulton, L. A. Fulton, H. S. Cordum, C. Wang, G. Elliott, J. Edwards, E. R. Mardis, L. G. Engstrand, and J. I. Gordon. 2006. The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. Proc. Natl. Acad. Sci. USA 103:9999-10004.[Abstract/Free Full Text]
    63. 62
  63. Orosz, A., I. Boros, and P. Venetianer. 1991. Analysis of the complex transcription termination region of the Escherichia coli rrnB gene. Eur. J. Biochem. 201:653-659.[Medline]
    64. 63
  64. Osorio, C. G., J. A. Crawford, J. Michalski, H. Martinez-Wilson, J. B. Kaper, and A. Camilli. 2005. Second-generation recombination-based in vivo expression technology for large-scale screening for Vibrio cholerae genes induced during infection of the mouse small intestine. Infect. Immun. 73:972-980.[Abstract/Free Full Text]
    65. 64
  65. Ottemann, K. M., and A. Lowenthal. 2002. Helicobacter pylori uses motility for both initial colonization and to attain robust infection. Infect. Immun. 70:1984-1990.[Abstract/Free Full Text]
    66. 65
  66. Oyarzabal, O. A., R. Rad, and S. Backert. 2007. Conjugative transfer of chromosomally encoded antibiotic resistance from Helicobacter pylori to Campylobacter jejuni. J. Clin. Microbiol. 45:402-408.[Abstract/Free Full Text]
    67. 66
  67. Parsonnet, J. 1995. The incidence of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 9(Suppl. 2):45-51.[Medline]
    68. 67
  68. Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Vogelman, N. Orentreich, and R. K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131.[Abstract]
    69. 68
  69. Pelicic, V., J. M. Reyrat, L. Sartori, C. Pagliaccia, R. Rappuoli, J. L. Telford, C. Montecucco, and E. Papini. 1999. Helicobacter pylori VacA cytotoxin associated with the bacteria increases epithelial permeability independently of its vacuolating activity. Microbiology 145:2043-2050.[Abstract/Free Full Text]
    70. 69
  70. Penfold, S. S., A. J. Lastovica, and B. G. Elisha. 1988. Demonstration of plasmids in Campylobacter pylori. J. Infect. Dis. 157:850-851.[Medline]
    71. 70
  71. Rohde, M., J. Puls, R. Buhrdorf, W. Fischer, and R. Haas. 2003. A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system. Mol. Microbiol. 49:219-234.[CrossRef][Medline]
    72. 71
  72. Saam, J. R., and J. I. Gordon. 1999. Inducible gene knockouts in the small intestinal and colonic epithelium. J. Biol. Chem. 274:38071-38082.[Abstract/Free Full Text]
    73. 72
  73. Salama, N. R., G. Otto, L. Tompkins, and S. Falkow. 2001. The vacuolating cytotoxin of Helicobacter pylori plays a role during colonization of a mouse model of infection. Infect. Immun. 69:730-736.[Abstract/Free Full Text]
    74. 73
  74. Salama, N. R., B. Shepherd, and S. Falkow. 2004. Global transposon mutagenesis and essential gene analysis of Helicobacter pylori. J. Bacteriol. 186:7926-7935.[Abstract/Free Full Text]
    75. 74
  75. Santos, D., and D. F. De Almeida. 1975. Isolation and characterization of a new temperature-sensitive cell division mutant of Escherichia coli K-12. J. Bacteriol. 124:1502-1507.[Abstract/Free Full Text]
    76. 75
  76. Satin, B., G. Del Giudice, V. Della Bianca, S. Dusi, C. Laudanna, F. Tonello, D. Kelleher, R. Rappuoli, C. Montecucco, and F. Rossi. 2000. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med. 191:1467-1476.[Abstract/Free Full Text]
    77. 76
  77. Saviola, B., S. C. Woolwine, and W. R. Bishai. 2003. Isolation of acid-inducible genes of Mycobacterium tuberculosis with the use of recombinase-based in vivo expression technology. Infect. Immun. 71:1379-1388.[Abstract/Free Full Text]
    78. 77
  78. Savvides, S. N., H. J. Yeo, M. R. Beck, F. Blaesing, R. Lurz, E. Lanka, R. Buhrdorf, W. Fischer, R. Haas, and G. Waksman. 2003. VirB11 ATPases are dynamic hexameric assemblies: new insights into bacterial type IV secretion. EMBO J. 22:1969-1980.[CrossRef][Medline]
    79. 78
  79. Scott, D. R., E. A. Marcus, Y. Wen, J. Oh, and G. Sachs. 2007. Gene expression in vivo shows that Helicobacter pylori colonizes an acidic niche on the gastric surface. Proc. Natl. Acad. Sci. USA 104:7235-7240.[Abstract/Free Full Text]
    80. 79
  80. Segal, E. D., S. Falkow, and L. S. Tompkins. 1996. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc. Natl. Acad. Sci. USA 93:1259-1264.[Abstract/Free Full Text]
    81. 80
  81. Smeets, L. C., J. J. E. Bijlsma, S. Y. Boomkens, C. M. J. E. Vandenbroucke-Grauls, and J. G. Kusters. 2000. comH, a novel gene essential for natural transformation of Helicobacter pylori. J. Bacteriol. 182:3948-3954.[Abstract/Free Full Text]
    82. 81
  82. Soma, A., Y. Ikeuchi, S. Kanemasa, K. Kobayashi, N. Ogasawara, T. Ote, J. Kato, K. Watanabe, Y. Sekine, and T. Suzuki. 2003. An RNA-modifying enzyme that governs both the codon and amino acid specificities of isoleucine tRNA. Mol. Cell 12:689-698.[CrossRef][Medline]
    83. 82
  83. Stark, W. M., N. D. Grindley, G. F. Hatfull, and M. R. Boocock. 1991. Resolvase-catalysed reactions between res sites differing in the central dinucleotide of subsite I. EMBO J. 10:3541-3548.[Medline]
    84. 83
  84. Szabo, I., S. Brutsche, F. Tombola, M. Moschiono, B. Satin, J. L. Telford, R. Rappuoli, C. Montecucco, E. Papini, and M. Zoratti. 1999. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J. 18:5517-5527.[CrossRef][Medline]
    85. 84
  85. Terry, K., S. M. Williams, L. Connolly, and K. M. Ottemann. 2005. Chemotaxis plays multiple roles during Helicobacter pylori animal infection. Infect. Immun. 73:803-811.[Abstract/Free Full Text]
    86. 85
  86. Tomb, J.-F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Lftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Tizegerald, N. Lee, M. D. Adams, E. K. Kichey, D. E. Berg, J. D. Gocayne, T. R. Utterback, J. D. Person, J. Kelley, M. D. Cotton, J. M. Weidman, C. Fujii, C. Bowman, L. Wathey, E. Wallin, W. S. Hayes, M. Borodovsky, P. D. Karp, H. O. Smith, C. M. Fraser, and J. C. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-547.[CrossRef][Medline]
    87. 86
  87. Uemura, N., S. Okamoto, S. Yamamoto, N. Matsumura, S. Yamaguchi, M. Yamakido, K. Taniyama, N. Sasaki, and R. J. Schlemper. 2001. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345:784-789.[Abstract/Free Full Text]
    88. 87
  88. Veal-Carr, W. L., and S. Stibitz. 2005. Demonstration of differential virulence gene promoter activation in vivo in Bordetella pertussis using RIVET. Mol. Microbiol. 55:788-798.[CrossRef][Medline]
    89. 88
  89. Viala, J., P. Sansonetti, and D. J. Philpott. 2004. Nods and ‘intracellular’ innate immunity. C. R. Biol. 327:551-555.[Medline]
    90. 89
  90. Waters, V. L. 2001. Conjugation between bacterial and mammalian cells. Nat. Genet. 29:375-376.[CrossRef][Medline]
    91. 90
  91. Wells, T. J., J. J. Tree, G. C. Ulett, and M. A. Schembri. 2007. Autotransporter proteins: novel targets at the bacterial cell surface. FEMS Microbiol. Lett. 274:163-172.[CrossRef][Medline]
    92. 91
  92. Yamaoka, Y., D. H. Kwon, and D. Y. Graham. 2000. A Mr 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc. Natl. Acad. Sci. USA 97:7533-7538.[Abstract/Free Full Text]
    93. 92
  93. Zhu, J., P. M. Oger, B. Schrammeijer, P. J. Hooykaas, S. K. Farrand, and S. C. Winans. 2000. The bases of crown gall tumorigenesis. J. Bacteriol. 182:3885-3895.[Free Full Text]

Infection and Immunity, December 2008, p. 5632-5644, Vol. 76, No. 12
0019-9567/08/$08.00+0     doi:10.1128/IAI.00627-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castillo, A. R.
Right arrow Articles by Ottemann, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castillo, A. R.
Right arrow Articles by Ottemann, K. M.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»